Gary K. Lee

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Mark Meltz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary K. Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Scientific Officer Common Stock 15.4K $248K $16.16 10 Nov 2025 Direct
Lyell Immunopharma, Inc. Chief Scientific Officer Option (right to buy) 68K 27 Oct 2025 Direct

Insider Reports Filed by Gary K. Lee

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYEL Lyell Immunopharma, Inc. 10 Nov 2025 1 -$2.23K 4 Chief Scientific Officer 12 Nov 2025, 20:33
LYEL Lyell Immunopharma, Inc. 27 Oct 2025 1 $0 4 Chief Scientific Officer 29 Oct 2025, 17:41
LYEL Lyell Immunopharma, Inc. 20 Aug 2025 2 -$15.3K 4 Chief Scientific Officer 22 Aug 2025, 16:02
LYEL Lyell Immunopharma, Inc. 11 Aug 2025 2 -$2.78K 4 Chief Scientific Officer 13 Aug 2025, 21:08
LYEL Lyell Immunopharma, Inc. 10 Feb 2025 3 $0 4 Chief Scientific Officer 26 Feb 2025, 19:27
LYEL Lyell Immunopharma, Inc. 09 Feb 2024 2 $0 4 Chief Scientific Officer 13 Feb 2024, 20:22
LYEL Lyell Immunopharma, Inc. 16 Nov 2023 2 $0 4 Chief Scientific Officer 20 Nov 2023, 20:54
LYEL Lyell Immunopharma, Inc. 24 Feb 2023 1 $0 4 Chief Scientific Officer 28 Feb 2023, 17:17
LYEL Lyell Immunopharma, Inc. 11 Feb 2022 1 $0 4 Chief Scientific Officer 14 Feb 2022, 19:59
LYEL Lyell Immunopharma, Inc. 31 Jan 2022 0 $0 3 Chief Scientific Officer 04 Feb 2022, 13:37